Health
UK begins trial of multivariant Covid-19 vaccine booster – The Tribune India
London, September 21
A phase one trial of a multivariant Covid-19 vaccine booster drug has got underway among participants aged over 60 in the UK.
The trial, involving GRT-R910, has been launched by US pharmaceutical company Gritstone in collaboration with…
Continue Reading
